Arrowhead Research (ARWR)

Add to Watchlists
Create an Alert
7.28 +0.05  +0.69% NASDAQ Apr 24, 8:00PM BATS Real time Currency in USD
View Full Chart
ARWR Price Chart
View All Events

ARWR Events

Date Type Description
03/03/2015 Misc Arrowhead Research Corp AGM
02/09/2015 16:30 EST Misc Arrowhead Research Corp First Quarter Earnings Conference Call in 2015
02/09/2015 Earnings Arrowhead Research Corp First Quarter Earnings in 2015 Release
11/25/2014 16:30 EST Misc Arrowhead Research Corp 4Q2014 Earning Conference Call
11/25/2014 Earnings Arrowhead Research Corp 4Q2014 Earning Results
11/10/2014 20:00 EST Misc Arrowhead Analyst and Investor
08/12/2014 Earnings Arrowhead Research Corp 3Q2014 Earning Result
08/12/2014 Misc Arrowhead Research Corp 3Q2014 Earning Conference Call
06/19/2014 12:30 EDT Misc Arrowhead Research Corporation Analyst Day
05/06/2014 16:30 EDT Misc Arrowhead Research Corp 2Q2014 Earning Conference Call
View All Performance Charts

ARWR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Arrowhead Research is down 43.09% over the last year vs S&P 500 Total Return up 15.24%, Achillion Pharmaceuticals up 226.6%, and Tekmira Pharmaceuticals up 26.21%.

Get Quote for
Advertisement

ARWR Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.arrowheadresearch.com
  • IR Website: http://www.arrowheadresearch.com/corporate-governance
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2015
  • Est. Current Fiscal Year End: September 30, 2015
  • Last Fiscal Quarter End: December 31, 2014
  • Last Fiscal Year End: September 30, 2014
  • Next Earnings Release: N/A
  • NAICS: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry: Scientific Research and Development Services
  • NAICS Sector: Professional, Scientific, and Technical Services

Arrowhead Research Corp is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company's drug candidate ARC-520 is designed to treat chronic hepatitis B infection.

ARWR Excel Add-In Codes

  • Name: =YCI("ARWR","name")
  • Description: =YCI("ARWR","description")
  • Sector: =YCI("ARWR","sector")
  • Industry: =YCI("ARWR","industry")
  • Est. Current Fiscal Year End: =YCI("ARWR","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.